サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451477

OTC人工涙液市場レポート：製品タイプ、容器タイプ、製剤、用途、流通チャネル、地域別、2024-2032

OTC Artificial Tears Market Report by Product, Container Type, Formulation, Application, Distribution Channel, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 146 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
OTC人工涙液市場レポート：製品タイプ、容器タイプ、製剤、用途、流通チャネル、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

OTC人工涙液の世界市場規模は2023年に52億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに78億米ドルに達し、2024～2032年の成長率（CAGR）は4.58％になると予測しています。

OTC人工涙液は、目の潤滑、目の痛み、不快感、灼熱感、充血、羞明、炎症を緩和するために使用される目薬です。デキストラン、グリセリン、プロピレングリコール、ヒドロキシプロピルメチルセルロース（HPMC）、カルボキシメチルセルロースを使用して製造されます。人工涙液はドライアイの治療に広く使用されています。ドライアイとは、結膜、角膜、または目の表面全体に十分な水分や潤滑が生成されない病状です。OTC人工涙液は生体適合性があり、涙液膜を安定させ、治癒を促進し、涙の蒸発を最小限に抑えます。これに加えて、OTC人工涙液は、軟膏、スプレー、乳液、溶液、ゲルなどの形態で販売されており、非常に便利に使用できます。

OTC人工涙液市場の動向：

慢性的な眼障害に罹患しやすい老年人口の増加は、市場の成長を促進する主な要因の1つです。ドライアイ症候群（DES）、糖尿病、栄養不足の有病率の増加により、目の不快感を即座に緩和するOTC人工涙液の需要が高まっています。さらに、スマートフォン、テレビ（TV）、ノートパソコンなどの電子機器の利用が増加し、画面の見過ぎや目の疲労につながっていることが、OTC人工涙液の採用にプラスの影響を与えています。瞬き活性化コーティングを強化した製品の市場開拓など、様々な製品革新が市場の成長を後押ししています。これらのコーティングは、蒸発性ドライアイ症候群を患う患者に眼に潤いを与えます。これに伴い、角膜への酸素の流れを促進し、目の表面の乾燥を防ぐためにコンタクトレンズが広く採用されていることも、市場の成長を後押ししています。その他の要因としては、特に都市部における汚染レベルの上昇や、大衆の健康意識の高まりなどが挙げられ、市場成長の原動力になると予想されます。

本レポートで扱う主な質問

  • 2023年のOTC人工涙液世界市場規模は？
  • 2024年～2032年のOTC人工涙液世界市場の予想成長率は？
  • OTC人工涙液の世界市場を牽引する主要因は何か？
  • COVID-19がOTC人工涙液の世界市場に与えた影響は？
  • OTC人工涙液世界市場の製品別区分は？
  • 容器タイプ別のOTC人工涙液世界市場内訳は？
  • 製剤別のOTC人工涙液世界市場の内訳は？
  • 用途別のOTC人工涙液世界市場内訳は？
  • OTC人工涙液世界市場の流通経路別区分は？
  • OTC人工涙液世界市場の主要地域は？
  • OTC人工涙液世界市場の主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 OTC人工涙液の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • ソリューション
    • 市場動向
    • 市場予測
  • 軟膏
    • 市場動向
    • 市場予測
  • エマルジョン
    • 市場動向
    • 市場予測
  • ゲル
    • 市場動向
    • 市場予測
  • スプレー液
    • 市場動向
    • 市場予測
  • 懸濁液
    • 市場動向
    • 市場予測

第7章 市場内訳：容器タイプ別

  • プラスチック単回投与容器
    • 市場動向
    • 市場展望
  • プラスチック多回用量容器
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：剤形別

  • 防腐剤ベース
    • 市場動向
    • 市場予測
  • 非防腐剤ベース
    • 市場動向
    • 市場予測

第9章 市場内訳：用途別

  • ドライアイ症候群
    • 市場動向
    • 市場予測
  • アレルギー
    • 市場動向
    • 市場予測
  • 感染症
    • 市場動向
    • 市場予測
  • 紫外線とブルーライト対策
    • 市場動向
    • 市場予測
  • コンタクトレンズ保湿
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • ドラッグストア・小売薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Akorn Inc.
    • Alcon
    • Bausch Health Companies Inc.
    • Johnson & Johnson
    • Nicox S.A.
    • OASIS Medical
    • OCuSOFT Inc.
    • Santen Pharmaceutical Co. Ltd.
    • Similasan Corporation
    • Sun Pharmaceutical Industries Ltd.
    • URSAPHARM Arzneimittel GmbH
図表

List of Figures

  • Figure 1: Global: OTC Artificial Tears Market: Major Drivers and Challenges
  • Figure 2: Global: OTC Artificial Tears Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: OTC Artificial Tears Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: OTC Artificial Tears Market: Breakup by Product (in %), 2023
  • Figure 5: Global: OTC Artificial Tears Market: Breakup by Container Type (in %), 2023
  • Figure 6: Global: OTC Artificial Tears Market: Breakup by Formulation (in %), 2023
  • Figure 7: Global: OTC Artificial Tears Market: Breakup by Application (in %), 2023
  • Figure 8: Global: OTC Artificial Tears Market: Breakup by Distribution Channel (in %), 2023
  • Figure 9: Global: OTC Artificial Tears Market: Breakup by Region (in %), 2023
  • Figure 10: Global: OTC Artificial Tears (Solution) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: OTC Artificial Tears (Solution) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: OTC Artificial Tears (Ointment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: OTC Artificial Tears (Ointment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: OTC Artificial Tears (Emulsion) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: OTC Artificial Tears (Emulsion) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: OTC Artificial Tears (Gel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: OTC Artificial Tears (Gel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: OTC Artificial Tears (Spray Solution) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: OTC Artificial Tears (Spray Solution) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: OTC Artificial Tears (Suspensions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: OTC Artificial Tears (Suspensions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: OTC Artificial Tears (Plastic Single Dose Container) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: OTC Artificial Tears (Plastic Single Dose Container) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: OTC Artificial Tears (Plastic Multi-Dose Container) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: OTC Artificial Tears (Plastic Multi-Dose Container) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: OTC Artificial Tears (Other Container Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: OTC Artificial Tears (Other Container Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: OTC Artificial Tears (Preservative Based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: OTC Artificial Tears (Preservative Based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: OTC Artificial Tears (Non-Preservative Based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: OTC Artificial Tears (Non-Preservative Based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: OTC Artificial Tears (Dry Eye Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: OTC Artificial Tears (Dry Eye Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: OTC Artificial Tears (Allergies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: OTC Artificial Tears (Allergies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: OTC Artificial Tears (Infections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: OTC Artificial Tears (Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: OTC Artificial Tears (UV and Blue Light Protection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: OTC Artificial Tears (UV and Blue Light Protection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: OTC Artificial Tears (Contact Lens Moisture Retention) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: OTC Artificial Tears (Contact Lens Moisture Retention) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: OTC Artificial Tears (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: OTC Artificial Tears (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: OTC Artificial Tears (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: OTC Artificial Tears (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: OTC Artificial Tears (Drug Store and Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: OTC Artificial Tears (Drug Store and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: OTC Artificial Tears (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: OTC Artificial Tears (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: North America: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: North America: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United States: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United States: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Canada: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Canada: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Asia-Pacific: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Asia-Pacific: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: China: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: China: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Japan: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Japan: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: India: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: India: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: South Korea: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: South Korea: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Australia: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Australia: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Indonesia: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Indonesia: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Europe: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Europe: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Germany: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Germany: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: France: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: France: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: United Kingdom: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: United Kingdom: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Italy: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Italy: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Spain: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Spain: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Russia: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Russia: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Latin America: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Latin America: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Brazil: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Brazil: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Mexico: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Mexico: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Others: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Others: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: Middle East and Africa: OTC Artificial Tears Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: Middle East and Africa: OTC Artificial Tears Market: Breakup by Country (in %), 2023
  • Figure 98: Middle East and Africa: OTC Artificial Tears Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Global: OTC Artificial Tears Industry: SWOT Analysis
  • Figure 100: Global: OTC Artificial Tears Industry: Value Chain Analysis
  • Figure 101: Global: OTC Artificial Tears Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: OTC Artificial Tears Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: OTC Artificial Tears Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: OTC Artificial Tears Market Forecast: Breakup by Container Type (in Million US$), 2024-2032
  • Table 4: Global: OTC Artificial Tears Market Forecast: Breakup by Formulation (in Million US$), 2024-2032
  • Table 5: Global: OTC Artificial Tears Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: OTC Artificial Tears Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 7: Global: OTC Artificial Tears Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: OTC Artificial Tears Market: Competitive Structure
  • Table 9: Global: OTC Artificial Tears Market: Key Players
目次
Product Code: SR112024A4958

The global OTC artificial tears market size reached US$ 5.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.58% during 2024-2032.

Over the Counter (OTC) artificial tears are eye drops that are used for lubricating eyes and providing relief from pain, discomfort, burning, redness, photophobia and irritation in the eyes. They are manufactured using dextran, glycerin, propylene glycol, hydroxypropyl methylcellulose (HPMC) and carboxymethylcellulose. Artificial tears are widely used for the treatment of dry eyes, which is a medical condition when sufficient moisture or lubrication is not generated on the conjunctiva, cornea or entire surface of the eye. OTC artificial tears are biocompatible and aid in stabilizing the tear film, promoting healing and minimizing tear evaporation. In addition to this, OTC artificial tears are also available in ointment, spray, emulsion, solution and gel forms that are highly convenient use.

OTC Artificial Tears Market Trends:

The rising geriatric population that is prone to chronic eye-related disorders is one of the key factors driving the growth of the market. Due to the increasing prevalence of dry eye syndrome (DES), diabetes and nutritional deficiencies, there is a rising demand for OTC artificial tears to provide immediate relief from discomfort in the eyes. Additionally, the increasing utilization of electronics, such as smartphones, televisions (TVs) and laptops, leading to excessive screen time and eye fatigue, is positively impacting the adoption of OTC artificial tears. Various product innovations, such as the development of variants fortified with blink-activated coatings, are providing a thrust to the market growth. These coatings provide ocular hydration to patients suffering from evaporative dry eye syndrome. In line with this, the widespread product adoption with contact lenses to facilitate the flow of oxygen to the cornea and prevent dryness on the surface of the eyes is favoring the market growth. Other factors, including rising levels of pollution, especially in the urban regions, along with the increasing health consciousness among the masses, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global OTC artificial tears market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, container type, formulation, application and distribution channel.

Breakup by Product:

Solution

Ointment

Emulsion

Gel

Spray Solution

Suspensions

Breakup by Container Type:

Plastic Single Dose Container

Plastic Multi-Dose Container

Others

Breakup by Formulation:

Preservative Based

Non-Preservative Based

Breakup by Application:

Dry Eye Syndrome

Allergies

Infections

UV and Blue Light Protection

Contact Lens Moisture Retention

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Drug Store and Retail Pharmacies

Online Pharmacies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Johnson & Johnson, Nicox S.A., OASIS Medical, OCuSOFT Inc., Santen Pharmaceutical Co. Ltd., Similasan Corporation, Sun Pharmaceutical Industries Ltd. and URSAPHARM Arzneimittel GmbH.

Key Questions Answered in This Report

  • 1. What was the size of the global OTC artificial tears market in 2023?
  • 2. What is the expected growth rate of the global OTC artificial tears market during 2024-2032?
  • 3. What are the key factors driving the global OTC artificial tears market?
  • 4. What has been the impact of COVID-19 on the global OTC artificial tears market?
  • 5. What is the breakup of the global OTC artificial tears market based on the product?
  • 6. What is the breakup of the global OTC artificial tears market based on the container type?
  • 7. What is the breakup of the global OTC artificial tears market based on formulation?
  • 8. What is the breakup of the global OTC artificial tears market based on the application?
  • 9. What is the breakup of the global OTC artificial tears market based on the distribution channel?
  • 10. What are the key regions in the global OTC artificial tears market?
  • 11. Who are the key players/companies in the global OTC artificial tears market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global OTC Artificial Tears Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Solution
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Ointment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Emulsion
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gel
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Spray Solution
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Suspensions
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Container Type

  • 7.1 Plastic Single Dose Container
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Plastic Multi-Dose Container
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Formulation

  • 8.1 Preservative Based
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-Preservative Based
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Dry Eye Syndrome
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Allergies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Infections
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 UV and Blue Light Protection
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Contact Lens Moisture Retention
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by Distribution Channel

  • 10.1 Hospital Pharmacies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Drug Store and Retail Pharmacies
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Online Pharmacies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 AbbVie Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Akorn Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Alcon
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Bausch Health Companies Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Johnson & Johnson
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Nicox S.A.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 OASIS Medical
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 OCuSOFT Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Santen Pharmaceutical Co. Ltd.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Similasan Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Sun Pharmaceutical Industries Ltd.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 URSAPHARM Arzneimittel GmbH
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio